BamSEC and AlphaSense Join Forces
Learn More

Syndax Pharmaceuticals Inc. – Material Contracts

NASDAQ: SNDX    
Share price (6/2/26): $18.39    
Market cap (6/2/26): $1.629 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.30
from 10-K 2 pages Syndax Pharmaceuticals, Inc. Amended & Restated Non-Employee Director Compensation Policy Effective: February 4, 2026
12/34/56
EX-10.1
from 8-K 23 pages Executive Employment Agreement
12/34/56
EX-10.43
from 10-K 62 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Purchase and Sale Agreement by and Between Syndax Pharmaceuticals, Inc. and Royalty Pharma Development Funding, LLC Dated as of November 4, 2024
12/34/56
EX-10.28
from 10-K 2 pages Syndax Pharmaceuticals, Inc. Amended & Restated Non-Employee Director Compensation Policy Effective: February 5, 2025
12/34/56
EX-10.16
from 10-K 25 pages Syndax Pharmaceuticals, Inc. 2023 Inducement Plan as Amended: December 6, 2023, July 22, 2024, December 19, 2024
12/34/56
EX-10.1
from 8-K 23 pages Executive Employment Agreement
12/34/56
EX-10.31
from 10-K 2 pages Syndax Pharmaceuticals, Inc. Amended & Restated Non-Employee Director Compensation Policy Effective: February 7, 2024
12/34/56
EX-10.30
from 10-K 2 pages Amendment to Executive Employment Agreement
12/34/56
EX-10.27
from 10-K 2 pages Amendment to Executive Employment Agreement
12/34/56
EX-10.25
from 10-K 2 pages Amendment to Executive Employment Agreement
12/34/56
EX-10.23
from 10-K 2 pages Amendment to Amended and Restated Executive Employment Agreement
12/34/56
EX-10.22
from 10-K 23 pages Amended & Restated Executive Employment Agreement
12/34/56
EX-10.20
from 10-K 2 pages Amendment to Amended and Restated Executive Employment Agreement
12/34/56
EX-10.16
from 10-K 25 pages Syndax Pharmaceuticals, Inc. 2023 Inducement Plan as Amended: December 6, 2023
12/34/56
EX-10
from 10-Q 6 pages Syndax Pharmaceuticals, Inc. 2023 Inducement Plan Stock Unit Agreement
12/34/56
EX-10
from 8-K 23 pages Executive Employment Agreement
12/34/56
EX-10
from 10-K 2 pages Syndax Pharmaceuticals, Inc. Amended & Restated Non-Employee Director Compensation Policy Effective: February 2, 2023
12/34/56
EX-10.2
from 8-K 6 pages Syndax Pharmaceuticals, Inc. 2023 Inducement Plan Nonqualified Option Agreement
12/34/56
EX-10.1
from 8-K 25 pages Syndax Pharmaceuticals, Inc. 2023 Inducement Plan
12/34/56
EX-10.1
from 8-K 23 pages Executive Employment Agreement
12/34/56